RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms
Braz. j. pharm. sci; 49 (2), 2013
Rivaroxaban, an anti-clotting medication, acts at a crucial point in the blood-clotting process and stops the formation of blood clots. In this study, RP-HPLC method was developed for the determination of rivaroxaban in tablets (Xarelto® (10 mg)). Phenomenex Luna 5 µm C18 100 Å LC Column (250 x 4.6 mm...